PC-SPES: hope or hype?
Michael P
MP
Kosty
D000925:Anticoagulants / Q000032:analysis; D018931:Antineoplastic Agents, Hormonal / Q000032:analysis; D000972:Antineoplastic Agents, Phytogenic / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000529:Complementary Therapies / Q000592:standards; D004054:Diethylstilbestrol / Q000032:analysis; D004340:Drug Contamination; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D015203:Reproducibility of Results; D014859:Warfarin / Q000032:analysis
D000925:Anticoagulants; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal; C114209:herbal preparation PC-SPES; D014859:Warfarin; D004054:Diethylstilbestrol; D017430:Prostate-Specific Antigen